-
Add new information to your contraceptive counseling databank: Findings from a just-published study indicate the absolute risk of increased thrombotic stroke and myocardial infarction (MI) associated with the use of hormonal contraception is low, although the relative risks vary depending on whether higher doses of estrogen are used.
-
The Centers for Disease Control and Prevention (CDC) has updated the U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC) to affirm the use of hormonal contraceptives in women at risk for or living with HIV.
-
Is azithromycin proarrhythmic? Macrolide antibiotics are associated with an increased risk of sudden cardiac death, but azithromycin (Zithromax), the popular "Z pack" macrolide, has been considered safe.
-
The authors sought to estimate trends in prenatal drug exposure and neonatal abstinence syndrome (NAS) in Washington State from 2000 to 2008.
-
You've seen her before. she's often young and partnered, but might be midlife and changing the status of her relationship. Sometimes she presents for an annual exam and mentions her pain later during the visit. Occasionally she actually presents with the complaint of dyspareunia.
-
Gestational diabetes (gdm) now complicates about one in 15 pregnancies, but, undoubtedly, the prevalence will increase even further if we cannot curb the concerning rise in obesity in this country.
-
-
The authors assessed the risk of venous thrombosis (vt) in current users of non-oral hormonal contraception using four national registries in Denmark.
-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Although the incidence of hysterectomy has declined in recent years, it remains the most common major gynecologic procedure, and many women are offered or consider elective bilateral oophorectomy (BSO) at the time of hysterectomy to reduce ovarian cancer risk.